Potokar JP - Search Results

1

Development and validation of the Generalized Anxiety Disorder Inventory (GADI).

Argyropoulos SV, Ploubidis GB, Wright TS, Palm ME, Hood SD, Nash JR, Taylor AC, Forshall SW, Anderson IM, Nutt DJ, Potokar JP. Argyropoulos SV, et al. Among authors: potokar jp. J Psychopharmacol. 2007 Mar;21(2):145-52. doi: 10.1177/0269881107069944. J Psychopharmacol. 2007. PMID: 17329293

2

A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers.

Bailey JE, Kendrick A, Diaper A, Potokar JP, Nutt DJ. Bailey JE, et al. Among authors: potokar jp. J Psychopharmacol. 2007 Jan;21(1):42-9. doi: 10.1177/0269881106063889. Epub 2006 Mar 13. J Psychopharmacol. 2007. PMID: 16533865 Clinical Trial.

3

Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders.

Davies SJ, Hood SD, Argyropoulos SV, Morris K, Bell C, Witchel HJ, Jackson PR, Nutt DJ, Potokar JP. Davies SJ, et al. Among authors: potokar jp. J Clin Psychopharmacol. 2006 Aug;26(4):414-8. doi: 10.1097/01.jcp.0000227704.79740.c0. J Clin Psychopharmacol. 2006. PMID: 16855462 Clinical Trial.

4

Generalized anxiety disorder: A comorbid disease.

Nutt D, Argyropoulos S, Hood S, Potokar J. Nutt D, et al. Eur Neuropsychopharmacol. 2006 Jul;16 Suppl 2:S109-18. doi: 10.1016/j.euroneuro.2006.04.003. Epub 2006 Jun 5. Eur Neuropsychopharmacol. 2006. PMID: 16737802 Review.

5

Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.

Hood SD, Hince DA, Davies SJ, Argyropoulos S, Robinson H, Potokar J, Nutt DJ. Hood SD, et al. Psychopharmacology (Berl). 2010 Feb;208(2):223-32. doi: 10.1007/s00213-009-1722-1. Epub 2009 Nov 21. Psychopharmacology (Berl). 2010. PMID: 19936713 Clinical Trial.

6

Effects of 7.5% CO2 challenge in generalized anxiety disorder.

Seddon K, Morris K, Bailey J, Potokar J, Rich A, Wilson S, Bettica P, Nutt DJ. Seddon K, et al. J Psychopharmacol. 2011 Jan;25(1):43-51. doi: 10.1177/0269881110364270. Epub 2010 Mar 16. J Psychopharmacol. 2011. PMID: 20233897 Clinical Trial.

7

Is the association of hypertension and panic disorder explained by clustering of autonomic panic symptoms in hypertensive patients?

Davies SJ, Jackson PR, Lewis G, Hood SD, Nutt DJ, Potokar JP. Davies SJ, et al. Among authors: potokar jp. J Affect Disord. 2008 Dec;111(2-3):344-50. doi: 10.1016/j.jad.2008.03.003. Epub 2008 Apr 29. J Affect Disord. 2008. PMID: 18448170

8

Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder.

Bell C, Hood S, Potokar J, Nash J, Adrover M, Frampton C, Hince D, Rich A, Argyropoulos S, Nutt D. Bell C, et al. Psychopharmacology (Berl). 2011 Feb;213(2-3):593-602. doi: 10.1007/s00213-009-1696-z. Epub 2009 Oct 13. Psychopharmacology (Berl). 2011. PMID: 19823804 Clinical Trial.

9

Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.

Bould H, Wiles N, Potokar J, Cowen P, Nutt DJ, Peters TJ, Lewis G. Bould H, et al. J Psychopharmacol. 2012 May;26(5):663-9. doi: 10.1177/0269881111431753. Epub 2012 Jan 4. J Psychopharmacol. 2012. PMID: 22223618 Clinical Trial.

10

Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomnia.

Wilson SJ, Rich AS, Rich NC, Potokar J, Nutt DJ. Wilson SJ, et al. Int Clin Psychopharmacol. 2004 Mar;19(2):77-84. doi: 10.1097/00004850-200403000-00004. Int Clin Psychopharmacol. 2004. PMID: 15076015 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters